1. Scientific and Medical Writing Steven “Moustafa” Kassem 2. Types of Medical and Scientific Writing Different publications 3. Medical Journalism Newspaper and Magazine…

1. Rationalefor RA A S blockade insecondary stroke prevention P reventionR egimenF orE ffectively avoidingS econdS trokes 2. American Stroke Association,’06 I-A-tp dopo…

1. Human Embryonic Stem Cells:Considerations forTherapeutic Development Jane Lebkowski Ph.D. Geron Corporation Cell, Tissue and Gene Therapy Advisory Committee Meeting April…

Slide 1FDA Medical Device Update US Food and Drug Administration New England District Slide 2 Position at NWE-DO Supervisory Investigator (May 2002) Monitor for Medical Device…

Slide 1EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance Slide 2 EPAA Conference…

1. How Do I Get Into Phase 1Trials With My Compound?Greg RuppertDirector, North American SalesMay 9, 2013 2. Preface and DisclaimerThis presentation is in regard to nonclinical…

1. Devang Barot Xiao Yin Phani Venkata Sekhar Puppala Hiral Parikh Instructor: Beverley Lach, MS R.A Sr. Lecturer 2. What is Evarrestand what is it used for?  Evarrest…

1. International Guidelines and Regulatory Agencies for Toxicity Studies Supervised by: Dr. Ajay Gaur H.O.D. Quality Assurance Submitted by: Sunil Saini M.Pharm (P`ceutics)…

5 Implant Stability - Measuring Devices and Randomized Clinical Trial for ISQ Value Change Pattern Measured from Two Different Directions by Magnetic RFA Jong-Chul Park,…

VALDOXAN ® – Product Information 1 (16) Version 10d VALDOXAN ® Product Information NAME OF THE MEDICINE VALDOXAN Agomelatine 25mg DESCRIPTION The active component of…